Advertisement
Heart Rhythm
Advanced searchSave search
Editorial Commentary|Articles in Press

Midline ablation beyond pulmonary vein isolation? “The MiLine study”

  • Wen-Han Cheng
    Affiliations
    Division of Cardiology, Department of Internal Medicine, National Yang Ming Chiao Tung University Hospital, Yilan, Taiwan

    Heart Rhythm Center, Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

    Institute of Clinical Medicine and Cardiovascular Research Institute, National Yang Ming Chiao Tung University, Taipei, Taiwan
    Search for articles by this author
  • Ying-Chieh Liao
    Affiliations
    Division of Cardiology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan

    Department of Post Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan
    Search for articles by this author
  • Shih-Ann Chen
    Correspondence
    Address reprint requests and correspondence: Dr Shih-Ann Chen, Cardiovascular Center Taichung Veterans General Hospital, 1650 Taiwan Blvd Sect. 4, Taichung, Taiwan.
    Affiliations
    Heart Rhythm Center, Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

    Institute of Clinical Medicine and Cardiovascular Research Institute, National Yang Ming Chiao Tung University, Taipei, Taiwan

    Department of Post Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan

    Cardiovascular Center, Taichung Veterans General Hospital, Taichung, Taiwan
    Search for articles by this author
Published:January 31, 2023DOI:https://doi.org/10.1016/j.hrthm.2023.01.033
Midline ablation beyond pulmonary vein isolation? “The MiLine study”
Previous ArticleEP News: Case Reports
Next ArticleFunctional characterization and identification of a therapeutic for a novel SCN5A-F1760C variant causing type 3 long QT syndrome refractory to all guideline-directed therapies
      For the past 2 decades, pulmonary vein isolation (PVI) has been established as the cornerstone of catheter ablation in atrial fibrillation (AF). Whereas PVI alone in paroxysmal AF was well-investigated, ablation targets in persistent AF were less determined.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Verma A.
        • Jiang C.Y.
        • Betts T.R.
        • et al.
        Approaches to catheter ablation for persistent atrial fibrillation.
        N Engl J Med. 2015; 372: 1812-1822
        View in Article
        • Marrouche N.F.
        • Wazni O.
        • McGann C.
        • et al.
        Effect of MRI-guided fibrosis ablation vs conventional catheter ablation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the DECAAF II randomized clinical trial.
        JAMA. 2022; 327: 2296-2305
        View in Article
        • Yang G.
        • Zheng L.
        • Jiang C.
        • et al.
        Circumferential pulmonary vein isolation plus low-voltage area modification in persistent atrial fibrillation: the STABLE-SR-II trial.
        JACC Clin Electrophysiol. 2022; 8: 882-891
        View in Article
        • Kistler P.M.
        • Chieng D.
        • Sugumar H.
        • et al.
        Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA randomized clinical trial.
        JAMA. 2023; 329: 127-135
        View in Article
        • Valderrábano M.
        • Peterson L.E.
        • Swarup V.
        • et al.
        Effect of catheter ablation with vein of Marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation: the VENUS randomized clinical trial.
        JAMA. 2020; 324: 1620-1628
        View in Article
        • Hwang J.
        • Park H.S.
        • Han S.
        • et al.
        Ablation of persistent atrial fibrillation based on high density voltage mapping and complex fractionated atrial electrograms: a randomized controlled trial.
        Medicine (Baltimore). 2021; 100e26702
        View in Article
        • Bergonti M.
        • Spera F.R.
        • Ferrero T.G.
        • et al.
        Anterior mitral line in patients with persistent AF and anterior scar: a multicenter matched comparison: the MiLine study.
        Heart Rhythm. 2023;
        View in Article
        • Yan H.
        • Thomas G.
        • Robert S.
        • et al.
        Low-voltage myocardium-guided ablation trial of persistent atrial fibrillation.
        NEJM Evid. 2022; 1EVIDoa2200141
        View in Article

      Article info

      Publication history

      Published online: January 31, 2023

      Publication stage

      In Press Journal Pre-Proof

      Footnotes

      Funding Sources: The authors have no funding sources to disclose.

      Disclosures: The authors have no conflicts of interest to disclose.

      Identification

      DOI: https://doi.org/10.1016/j.hrthm.2023.01.033

      Copyright

      © 2023 Heart Rhythm Society. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      Linked Article

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX